Antiplatelet drugs increase risk for TAVR patients with atrial fibrillation
(American College of Cardiology) Patients with atrial fibrillation who took oral anticoagulants alone after undergoing transcatheter aortic valve replacement (TAVR) had a lower rate of bleeding complications without an increased risk of clotting-related complications compared to patients who took antiplatelet medication in addition to oral anticoagulants, in a trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2020 Category: International Medicine & Public Health Source Type: news
TAVR shows favorable safety in patients with bicuspid valve
(American College of Cardiology) Transcatheter aortic valve replacement (TAVR) procedures had a high rate of success and low risk of death or disabling stroke at 30 days in patients with a bicuspid, or two-leaflet, aortic valve, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2020 Category: International Medicine & Public Health Source Type: news
Study finds room for improvement in TAVR outcomes across US
(American College of Cardiology) Thirty-four medical centers, representing 11% of facilities that perform transcatheter aortic valve replacement (TAVR) in the U.S., saw worse than expected outcomes in terms of survival and quality of life among patients undergoing the procedure in an analysis presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2020 Category: International Medicine & Public Health Source Type: news
TAVR found non-inferior to surgery in broad patient population
(American College of Cardiology) Patients who underwent transcatheter aortic valve replacement (TAVR) did not have a higher rate of death at one year compared with those who had their heart valve replaced via open-heart surgery, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 30, 2020 Category: International Medicine & Public Health Source Type: news
Landmark Phase 3 VOYAGER PAD Study of XARELTO ® (rivaroxaban) Plus Aspirin Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease (PAD) after Lower-Extremity Revascularization
RARITAN, NJ, March 28, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg once daily) was superior to aspirin alone in reducing the risk of major adverse limb and cardiovascular (CV) events by 15 percent in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization, with similar rates of TIMI[1] major bleeding. VOYAGER PAD is the only study to show a significant benefit using...
Source: Johnson and Johnson - March 28, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session
RARITAN, N.J., March 20, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it will unveil late-breaking data from its leading cardiovascular and metabolism portfolio during the virtual American College of Cardiology’s 69th Annual Scientific Session together with the World Congress of Cardiology (ACC.20/WCC) on March 28-30, 2020. Notably, four late-breaking abstracts for XARELTO® (rivaroxaban) will be presented, including data from the Phase 3 VOYAGER PAD study in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization.Click to Tweet: Jan...
Source: Johnson and Johnson - March 20, 2020 Category: Pharmaceuticals Source Type: news
Abbott Aims to Optimize TAVI Implants with European Approval of FlexNav(TM) Delivery System for the Company's Portico(TM) Valve
New FlexNav delivery system improves control and delivery of the Portico TAVI valve even in complex clinical cases
The minimally invasive Portico procedure allows doctors to treat severe aortic valve stenosis without invasive surgery
Approval of th... Devices, Interventional, Cardiology, Regulatory Abbott, FlexNav, Portico, transcatheter, aortic valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 5, 2020 Category: Pharmaceuticals Source Type: news
3D printing improves accuracy of knee arthroplasty
A new technique that relies on 3D-printed surgical guides designed with CT...Read more on AuntMinnie.comRelated Reading:
Can ultrasound, 3D printing deepen maternal-fetal bonds?
Can 3D printing help optimize cardiac CT protocols?
3D printing may improve safety of upper GI surgery
3D-printed head customizes neurosurgery simulation
3D printing technique improves heart valve sizing (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 3, 2020 Category: Radiology Source Type: news
Persistent Mitral Regurgitation After TAVR Bodes Ill in Some Persistent Mitral Regurgitation After TAVR Bodes Ill in Some
Patients with low-flow, low-gradient aortic stenosis (LFLG-AS) who don ' t show improvement in mitral regurgitation following transcatheter aortic-valve replacement (TAVR) face an increased risk of mortality, according to a substudy of a multicenter registry.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 26, 2020 Category: Radiology Tags: Cardiology News Source Type: news
Successful transcatheter mitral valve repair that enhances postoperative recovery
(Osaka University) Researchers at Osaka University succeed in Japan's first beating-heart surgery to repair a mitral valve without using artificial heart lung apparatus. This approach can avoid complications arising from the use of artificial heart lung apparatus, and more favorable and earlier postoperative recovery is expected. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 25, 2020 Category: International Medicine & Public Health Source Type: news
Cardiovalve Reaches 2 Milestones for its Tricuspid Valve Replacement System
Cardiovalve has a pair of milestones that could help catapult the company into the forefront of the tricuspid valve market. The Or Yehuda, Israel-based company received FDA approval for an early feasibility study of the transcatheter tricuspid valve replacement system and Breakthrough Device Designation for the technology.
The study’s primary endpoint is the safety and feasibility of the Cardiovalve technology and procedure in reducing tricuspid regurgitation, with evaluations at 30 days and periodically up to five years. The study will be conducted in collaboration with five leading US hospitals.
In a re...
Source: MDDI - February 21, 2020 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Cardiovascular Source Type: news
FDG-PET/CT points to cervical cancer patient outcomes
Several indicators on pretreatment FDG-PET/CT scans can help predict overall...Read more on AuntMinnie.comRelated Reading:
Biomarkers on PET, MRI show breast cancer risk
FDG-PET/CT within a year of heart valve surgery looks safe
FDG-PET/CT helps predict tuberculosis relapse
2 new PET tracers may best FDG in cancer imaging
FDG-PET/CT aids in melanoma treatment assessment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 13, 2020 Category: Radiology Source Type: news
Can 3D printing help optimize cardiac CT protocols?
Patient-specific 3D-printed coronary models have allowed clinicians to determine...Read more on AuntMinnie.comRelated Reading:
3 ways to advance 3D printing in radiology
AR, 3D printing make waves in cardiac care
3D printing helps unravel rare cardiac anomalies
3D printing technique improves heart valve sizing
3D printing gives pediatric heart surgery a boost (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 7, 2020 Category: Radiology Source Type: news
Oregon man becomes first to receive minimally invasive heart valve repair
The tricuspid valve, on the right side of the heart between the top and bottom chambers, is very tricky to repair because of its complexity.
Until recently, the only option was open-heart surgery.
But an Oregon man recently became the first patient in a new clinical trial to have the valve repaired with a minimally invasive procedure.
Dennis Eggers, a 73-year-old from Sweet Home, Oregon, said he’s feeling “very well,” about two months after his mid-December valve repair at Oregon Health… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 5, 2020 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news
Five-Year Outcomes Comparable for TAVR, Surgical AVR
TUESDAY, Feb. 4, 2020 -- There is no significant difference in the incidence of death or disabling stroke at five years among patients with aortic stenosis at intermediate surgical risk who undergo transcatheter aortic valve replacement (TAVR) or... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 4, 2020 Category: Pharmaceuticals Source Type: news
